BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Press Releases

  Modular Medical to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 on September 15-16, 2026

  September 8, 2026

   · 

  1 min read
• Press Releases

  Clinical Trial for an Oral Drug to Treat Ebola is Registered in the Pan African Clinical Trials Database and is Ready to Go, As the Largest Ebola Outbreak Continues to Expand in DR Congo

  September 8, 2026

   · 

  22 min read
• Press Releases

  Encoded Therapeutics Presents Updated Data from POLARIS Phase 1/2 Trials of ETX101 Gene Therapy in Dravet Syndrome at the 16th European Epilepsy Congress

  September 8, 2026

   · 

  6 min read
• Press Releases

  Endeavor BioMedicines Presents New Quantitative Imaging Data from Analysis of Phase 2a Clinical Trial Evaluating Taladegib (ENV-101) in Patients with Idiopathic Pulmonary Fibrosis

  September 8, 2026

   · 

  4 min read
• Press Releases

  Applied BioCode Announces Distribution Agreement with Henry Schein

  September 8, 2026

   · 

  1 min read
• Press Releases

  Coya Therapeutics Announces Publication of Preclinical Study Demonstrating Combination Immunomodulatory Effects of COYA 303 in a Well-Established Model of Peripheral and CNS Inflammation

  September 8, 2026

   · 

  6 min read
• Press Releases

  Lineage Cell Therapeutics Announces Issuance of Patent Underlying Its AlloSCOPE™ 5D Manufacturing Platform

  September 8, 2026

   · 

  13 min read
• Press Releases

  Prilenia Appoints Frederick (Rick) Munschauer, MD, FAAN, as Chief Medical Officer

  September 8, 2026

   · 

  3 min read
• Press Releases

  RiboX Therapeutics Receives U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RXRG001 for the Treatment of Radiation-Induced Xerostomia and Hyposalivation

  September 8, 2026

   · 

  4 min read
• Press Releases

  Agilent Announces Retirement of Board Chair Koh Boon Hwee, Appointment of Glenn Boehnlein to Board of Directors

  September 8, 2026

   · 

  3 min read